Prestige Brands Holdings Inc.
90 North Broadway
Irvington,
NY 10533
United States - Map
Phone: 914-524-6810
Fax: 914-524-6815
Web Site: http://www.prestigebrandsinc.com
| Prestige Brands Holdings, Inc., together with its subsidiaries, engages in the marketing, sale, and distribution of over-the-counter healthcare, household cleaning, and personal care products primarily in the United States and Canada. The companys Over-The-Counter Healthcare segment offers treatments for sore throat relief, eye redness relief, wart removal, bruxism, oral care, pediatric healthcare, personal ear care, liquid bandages, and pain relief sprays. It offers these products under the Clear Eyes, Murine, Chloraseptic, Compound W, Wartner, Little Remedies, The Doctors NightGuard, New-Skin, Dermoplast, Percogesic, Momentum, Mosco, Outgro, Sleep-Eze, and Compoz brand names. Prestige Brands Holdings Household Cleaning segment markets household cleaning products, such as abrasive and non-abrasive tub and tile cleaner, soap free metal scrubbers and sponges, and dilutable all purpose cleaning products under the Comet, Chore Boy, and Spic and Span brands. The companys Personal Care segment offers Cutex nail products, EZO denture cushion, Oxipor, Cloverine skin salve, and Kerodex barrier cream. It sells products through various channels, including mass merchandisers, drug, grocery, and dollar and club stores. Prestige Brands Holdings was founded in 1996 and is headquartered in Irvington, New York. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Peter J. Anderson , 54
Chief Financial Officer |
$
342.00K |
$
0 | Ms. Jean A. Boyko Ph.D., 53
Sr. VP of Science & Technology |
$
250.00K |
$
0 | Mr. Charles N. Jolly , 66
Sec. and Gen. Counsel |
$
333.00K |
$
0 | Mr. Matthew M. Mannelly ,
Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Lieven Nuyttens ,
Sr. VP of Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
Profile
